Omeprazol Antibiotice (Omeprazole)

Omeprazole, the active ingredient in Omeprazol Antibiotice, is a proton pump inhibitor presented as a 20 mg tablet for oral use. It reduces stomach acid production and is used to treat acid‑related disorders in adults and children.

GNH USA supplies Omeprazol Antibiotice as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Omeprazole acts on the gastric proton pump to manage conditions linked to excess stomach acid. - Gastro‑esophageal reflux disease (GERD): provides symptomatic relief and promotes healing of the esophageal lining. - Peptic ulcer disease: supports ulcer healing and reduces recurrence risk. - Zollinger‑Ellison syndrome: controls gastric acid hypersecretion associated with the condition.

Adverse reactions to omeprazole are generally mild and dose‑dependent.

Common Side Effects: - Headache: mild, transient headache reported by some patients. - Diarrhea: loose stools occurring during early treatment. - Nausea: occasional feeling of queasiness. - Abdominal pain: mild discomfort in the stomach area. - Flatulence: increased gas formation. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis linked to altered gut flora. - Acute interstitial nephritis: sudden kidney inflammation. - Stevens‑Johnson syndrome: rare severe skin reaction. - Hypersensitivity reactions: rash, itching, swelling, or anaphylaxis. - Low magnesium levels: prolonged use may cause hypomagnesemia. - Fracture risk: long‑term therapy associated with increased bone fracture incidence.

When using omeprazole, consider the following safety measures: - Assess renal function: adjust use in patients with severe kidney impairment. - Monitor for infections: be alert for signs of Clostridioides difficile infection. - Evaluate bone health: long‑term use may affect calcium absorption. - Review concomitant medications: potential interactions may require dose adjustments. - Pregnancy and lactation: use only if clearly needed after risk‑benefit assessment. - Store at below 25°C: keep in the original container, protect from moisture and direct sunlight.

Omeprazole can affect the plasma levels of several co‑administered drugs.

Major Interactions (Avoid): - Ketoconazole oral: reduced absorption leading to therapeutic failure. - Atazanavir: decreased plasma concentrations compromising antiviral efficacy. - Clopidogrel: diminished antiplatelet effect increasing cardiovascular risk.

Moderate Interaction -   : - Warfarin: may enhance anticoagulant effect, requiring INR monitoring. - Phenytoin: may lower phenyacillin ?  - Mycobacter  ??  

--- ---   ---